The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention
Open accessAbstract
Hepatocellular carcinoma (HCC) is the most well-known primary liver malignancy worldwide. Its incidence is rising at alarming rates and has become a public concern globally. It is more frequent in developing countries than in industrialized countries with respect to geographical variation, ethnic disparities and socioeconomic status. Dietary exposure to aflatoxins is among the major HCC risk factors. Aflatoxin B1, which is a genotoxic hepatocarcinogen, which presumptively causes cancer by inducing DNA adducts leading to genetic changes in target liver cells. AFB1 is metabolized by cytochrome-P450 enzymes to the reactive intermediate AFB1-8, 9 epoxide (AFBO) which binds to liver cell DNA, resulting in DNA adducts. DNA adducts interact with the guanine bases of liver cell DNA and cause a mutational effect in the P53 tumor suppressor gene at the codon 249 hotspot in exon 7, which may lead to HCC. Approximately 4.5 billion of the world's population is exposed to aflatoxin‑contaminated food, particularly in low‑income countries. Prevention involves treating crops that are susceptible to fungal contamination, appropriate handling of foodstuffs and the use of chemopreventive intervention. Moreover, an integrated network collaboration of different sectors, including public health, agricultural departments and mass media, is required to ensure effective food regulation systems so as to minimize the contamination of food by aflatoxins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Bennett, J. W., & Klich, M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.497-516.2003 · Cited by 3,127
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Cancer is a preventable disease that requires major lifestyle changes
Anand, P., Kunnumakara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., Sung, B., & Aggarwal, B. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9661-9 · Cited by 2,632
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Cancer Disparities by Race/Ethnicity and Socioeconomic Status
Ward, E., Jemal, A., Cokkinides, V., Singh, G. K., Cardinez, C., Ghafoor, A., & Thun, M. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.78 · Cited by 1,801
Williams, J. H., Phillips, T. D., Jolly, P. E., Stiles, J. K., Jolly, C. M., & Aggarwal, D. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1106 · Cited by 1,781
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Mechanisms of Aflatoxin Carcinogenesis
Eaton, D. L., & Gallagher, E. P. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001031 · Cited by 774
Lewis, L., Onsongo, M., Njapau, H., Schurz-Rogers, H., Luber, G., Kieszak, S., Nyamongo, J., Backer, L., Dahiye, A. M., Misore, A., et al. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7998 · Cited by 769
McCracken, M., Olsen, M., Chen, M. S., Jemal, A., Thun, M., Cokkinides, V., Deapen, D., & Ward, E. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.4.190 · Cited by 608
The toxicology of aflatoxins as a basis for public health decisions
Wild, C. P. (2002) · Mutagenesis · doi:10.1093/mutage/17.6.471 · Cited by 475
Epidemiological characteristics and risk factors of hepatocellular carcinoma
CHEN, C., YU, M., & LIAW, Y. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00513.x · Cited by 470
p53 mutation in hepatocellular carcinoma after aflatoxin exposure
Bressac, B., Puisieux, A., Kew, M., Volkmann, M., Bozcall, S., Bella Mura, J., de la Monte, S., Carlson, R., Blum, H., Wands, J., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)92236-u · Cited by 449
Hepatocellular Carcinoma: Epidemiology, Risk Factors, and Screening
Sherman, M. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871194 · Cited by 404
Epidemiology and natural history of hepatocellular carcinoma
McGlynn, K. A., & London, W. T. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.10.004 · Cited by 373
Nutrition and dietary carcinogens
Sugimura, T. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.387 · Cited by 365
The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis
Smela, M. E., Currier, S. S., Bailey, E. A., & Essigmann, J. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.4.535 · Cited by 362
Wang, J.-S., & Groopman, J. D. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00017-2 · Cited by 354
Activation and detoxication of aflatoxin B1
Guengerich, F. P., Johnson, W. W., Shimada, T., Ueng, Y.-F., Yamazaki, H., & Langouët, S. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(97)00289-3 · Cited by 344
Mycotoxins: Their implications for human and animal health
Fink‐Gremmels, J. (1999) · Veterinary Quarterly · doi:10.1080/01652176.1999.9695005 · Cited by 329
Epidemiology, Risk Factors, and Natural History of Hepatocellular Carcinoma
MONTALTO, G., CERVELLO, M., GIANNITRAPANI, L., DANTONA, F., TERRANOVA, A., & CASTAGNETTA, L. A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04090.x · Cited by 312
Turner, P., Sylla, A., Gong, Y., Diallo, M., Sutcliffe, A., Hall, A., & Wild, C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66661-5 · Cited by 312
Hepatocellular Carcinoma: From Gene to Public Health
Montesano, R., Hainaut, P., & Wild, C. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.24.1844 · Cited by 269
Gallagher, E. P., Kunze, K. L., Stapleton, P. L., & Eaton, D. L. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0326 · Cited by 267
Cellular interactions and metabolism of aflatoxin: An update
McLean, M., & Dutton, M. F. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00054-7 · Cited by 262
Sabbioni, G., Skipper, P. L., Büchi, G., & Tannenbaum, S. R. (1987) · Carcinogenesis · doi:10.1093/carcin/8.6.819 · Cited by 245
Primary prevention of hepatocellular carcinoma in developing countries
Wild, C. P., & Hall, A. J. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00027-2 · Cited by 226
Egal, S., Hounsa, A., Gong, Y. Y., Turner, P. C., Wild, C. P., Hall, A. J., Hell, K., & Cardwell, K. F. (2005) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2005.03.004 · Cited by 197
Wang, J. S., Huang, T., Su, J., et al. (2001) · PubMed · Cited by 170
Fusaria and fumonisins in maize from Ghana and their co-occurrence with aflatoxins
Kpodo, K. A., Thrane, U., & Hald, B. (2000) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(00)00370-6 · Cited by 142
Cancer chemoprevention by dietary constituents: a tale of failure and promise
Gescher, A. J., Sharma, R. A., & Steward, W. P. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00392-2 · Cited by 125
Biological Relevance of Adduct Detection to the Chemoprevention of Cancer
Sharma, R. A., & Farmer, P. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0098 · Cited by 114
Stern, M. C., Umbach, D. M., Yu, M. C., London, S. J., Zhang, Z., & Taylor, J. A. (2001) · PubMed · Cited by 112
Self-citationPathology and Pathogenesis of Hepatocellular Carcinoma
Röcken, C., & Carl‐McGrath, S. (2001) · Digestive Diseases · doi:10.1159/000050693 · Cited by 109
Cavin, C., Marin‐Kuan, M., Langouët, S., Bezençon, C., Guignard, G., Verguet, C., Piguet, D., Holzhäuser, D., Cornaz, R., & Schilter, B. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.09.099 · Cited by 109
Ilic, Z., Crawford, D. R., Egner, P. A., & Sell, S. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.10.008 · Cited by 105
Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients
Jackson, P. E. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg101 · Cited by 105
Brahmi, D., Bouaziz, C., Ayed, Y., Mansour, H. B., Zourgui, L., & Bacha, H. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-73 · Cited by 98
Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
McGlynn, K. A., Hunter, K. W., LeVoyer, T. E., Roush, J., Wise, P., Michielli, R. A., Shen, F.-M., Evans, A. A., London, W. T., & Buetow, K. H. (2003) · PubMed · Cited by 96
Tumor suppressor and hepatocellular carcinoma
Martin, J., & Dufour, J.-F. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1720 · Cited by 95
Nguyen, M. H., Whittemore, A. S., Garcia, R. T., Tawfeek, S. A., Ning, J., Lam, S., Wright, T. L., & Keeffe, E. B. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00353-2 · Cited by 90
Groß‐Steinmeyer, K., Stapleton, P. L., Tracy, J. H., Bammler, T. K., Strom, S. C., & Eaton, D. L. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq135 · Cited by 87
Madden, C. R., Finegold, M. J., & Slagle, B. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11770-11774.2002 · Cited by 73
Trudo, S. P., Lampe, J. W., Bammler, T. K., Groß‐Steinmeyer, K., & Eaton, D. L. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.04.010 · Cited by 72
Awuah, R. T., & Kpodo, K. A. (1996) · Mycopathologia · doi:10.1007/bf00436873 · Cited by 69
Obuseh, F. A., Jolly, P. E., Kulczycki, A., Ehiri, J. E., Waterbor, J. W., Desmond, R. A., Preko, P. O., Jiang, Y., & Piyathilake, C. J. (2011) · Journal of the International AIDS Society · doi:10.1186/1758-2652-14-53 · Cited by 67
Bypass of Aflatoxin B1 Adducts by the Sulfolobus solfataricus DNA Polymerase IV
Banerjee, S., Brown, K. L., Egli, M., & Stone, M. P. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2015668 · Cited by 37
Determinants of the Variability of Aflatoxin–Albumin Adduct Levels in Ghanaians
Dash, B., Afriyie-Gyawu, E., Huebner, H. J., Porter, W. W., Wang, J. S., Jolly, P. E., & Phillips, T. D. (2006) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390600748880 · Cited by 35
Lord, R., Suddle, A. R., & Ross, P. J. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02545.x · Cited by 27
Synergistic Effect of Hepatitis B Virus and Aflatoxin B1 in Hepatocarcinogenesis in Tree Shrews
Li, Y., Su, J. A. K. S., Ll, Q., et al. (1999) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v28n1p67 · Cited by 18
Survey of aflatoxins in Kashkineh: A traditional Iranian food.
Mardani, M., Rezapour, S., & Rezapour, P. (2011) · PubMed Central · Cited by 17
Cited by
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.001 · Cited by 851
Awuchi, C. G., Ondari, E. N., Ogbonna, C. U., Upadhyay, A. K., Baran, K., Okpala, C. O. R., Korzeniowska, M., & Guiné, R. P. F. (2021) · Foods · doi:10.3390/foods10061279 · Cited by 421
Barnes, J. L., Zubair, M., John, K., Poirier, M. C., & Martin, F. L. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180519 · Cited by 318
Benkerroum, N. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17041215 · Cited by 286
Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
Alqahtani, A., Khan, Z., Alloghbi, A., S. Said Ahmed, T., Ashraf, M., & M. Hammouda, D. (2019) · Medicina · doi:10.3390/medicina55090526 · Cited by 265
“The global distribution patterns of HCC reflect geographical variation, ethnic disparities, specific etiological factors, and socioeconomic status [9,10].”
Background
Metadata
- Authors
- HAMID, A. S., TESFAMARIAM, I. G., ZHANG, Y., & ZHANG, Z. G.
- Venue
- Oncology Letters
- Publisher
- Spandidos Publications
- Published
- 2013-01-31
- Volume
- 5
- Issue
- 4
- Pages
- 1087-1092
- ISSN
- 1792-1074 (ISSN-L)
- 1792-1082
- OpenAlex
- W2040032718
- Cited by
- 339
- References
- 56
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.